Next Article in Journal
Merkel Cell Carcinoma of the Eyelid and Periocular Region
Next Article in Special Issue
Mechanisms of Cancer Induction by Tobacco-Specific NNK and NNN
Previous Article in Journal
CCL21 Cancer Immunotherapy
Previous Article in Special Issue
Impact of Neuro-Psychological Factors on Smoking-Associated Lung Cancer
Article Menu

Export Article

Open AccessArticle
Cancers 2014, 6(2), 1111-1127;

The Role of Neutrophil Myeloperoxidase in Models of Lung Tumor Development

Department of Pharmacology and Toxicology and MCW Cancer Center, Medical College of Wisconsin, Milwaukee, WI 53226, USA
Department of Surgery, Washington University in St. Louis, St. Louis, MO 63130, USA
Department of Pathology, Medical College of Wisconsin, Milwaukee, WI 53226, USA
Department of Surgery and MCW Cancer Center, Medical College of Wisconsin, Milwaukee, WI 53226, USA
Current address: University of Wisconsin Milwaukee, Milwaukee, WI 53201, USA.
Author to whom correspondence should be addressed.
Received: 4 March 2014 / Revised: 11 April 2014 / Accepted: 6 May 2014 / Published: 9 May 2014
(This article belongs to the Special Issue Tobacco-related Cancers)
Full-Text   |   PDF [1057 KB, uploaded 13 May 2014]   |  


Chronic inflammation plays a key tumor-promoting role in lung cancer. Our previous studies in mice demonstrated that neutrophils are critical mediators of tumor promotion in methylcholanthrene (MCA)-initiated, butylated hydroxytoluene (BHT)-promoted lung carcinogenesis. In the present study we investigated the role of neutrophil myeloperoxidase (MPO) activity in this inflammation promoted model. Increased levels of MPO protein and activity were present in the lungs of mice administered BHT. Treatment of mice with N-acetyl lysyltyrosylcysteine amide (KYC), a novel tripeptide inhibitor of MPO, during the inflammatory stage reduced tumor burden. In a separate tumor model, KYC treatment of a Lewis Lung Carcinoma (LLC) tumor graft in mice had no effect on tumor growth, however, mice genetically deficient in MPO had significantly reduced LLC tumor growth. Our observations suggest that MPO catalytic activity is critical during the early stages of tumor development. However, during the later stages of tumor progression, MPO expression independent of catalytic activity appears to be required. Our studies advocate for the use of MPO inhibitors in a lung cancer prevention setting. View Full-Text
Keywords: neutrophils; myeloperoxidase; KYC; lung; tumor neutrophils; myeloperoxidase; KYC; lung; tumor

Figure 1

This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Share & Cite This Article

MDPI and ACS Style

Rymaszewski, A.L.; Tate, E.; Yimbesalu, J.P.; Gelman, A.E.; Jarzembowski, J.A.; Zhang, H.; Pritchard Jr., K.A.; Vikis, H.G. The Role of Neutrophil Myeloperoxidase in Models of Lung Tumor Development. Cancers 2014, 6, 1111-1127.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Cancers EISSN 2072-6694 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top